GeneDx Holdings Corp.
WGSWWNasdaq
$0.00
↑ +33.3%Jul 17 close · end-of-day
Price
1Y↓ -98.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$23,468.10
Enterprise Value
-$73.9M
P/E
—
P/S
0.0
P/B
0.0
EV/EBITDA
—
PEG
—
FCF Yield
-122089.1%
Dividend Yield
—
Revenue (TTM)
$442.7M
Net Income (TTM)
-$77.8M
Free Cash Flow (TTM)
-$28.7M
Gross Margin
69.6%
Operating Margin
-14.9%
Net Margin
-17.6%
ROE
-30.6%
ROIC
-28.9%
Debt / Equity
0.4
Net Cash
$74.0M
Return 1Y
-98.3%
Earnings
WGSWW Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$102.3M↑ +17.4%
Diluted EPS-$2.16↑ +839.1%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $179.3M | $212.2M | $234.7M | $202.6M | $305.4M | $427.5M |
| Gross profit | $4.0M | -$16.6M | -$26.8M | $90.0M | $194.4M | $298.2M |
| Operating income | -$242.0M | -$446.1M | -$667.7M | -$180.6M | -$23.2M | -$13.1M |
| Net income | -$241.3M | -$245.4M | -$549.0M | -$175.8M | -$52.3M | -$21.0M |
| Diluted EPS | -$47,036.00 | -$2.27 | -$53.63 | -$7.23 | -$1.94 | -$0.73 |
| Operating cash flow | -$93.1M | -$190.4M | -$319.2M | -$180.1M | -$28.5M | $33.3M |
| Free cash flow | -$117.2M | -$199.8M | -$326.3M | -$185.4M | -$34.0M | $14.3M |
| Gross margin | 2.2% | -7.8% | -11.4% | 44.4% | 63.6% | 69.7% |
| Operating margin | -134.9% | -210.3% | -284.5% | -89.2% | -7.6% | -3.1% |
| Net margin | -134.6% | -115.6% | -233.9% | -86.8% | -17.1% | -4.9% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $70.5M | $76.9M | $95.6M | $87.1M | $102.7M | $116.7M | $121.0M | $102.3M |
| Gross profit | $43.0M | $47.8M | $66.2M | $58.5M | $70.9M | $84.5M | $84.3M | $68.2M |
| Operating income | -$10.6M | -$7.8M | $8.8M | -$4.6M | $9.0M | -$3.3M | -$14.2M | -$57.5M |
| Net income | -$29.2M | -$8.3M | $5.4M | -$6.5M | $10.8M | -$7.6M | -$17.6M | -$63.3M |
| Diluted EPS | -$1.10 | -$0.31 | $0.25 | -$0.23 | $0.36 | -$0.27 | -$0.59 | -$2.16 |
| Operating cash flow | -$4.5M | -$4.4M | -$3.2M | $10.2M | $10.4M | $15.8M | -$3.1M | -$32.4M |
| Free cash flow | -$5.9M | -$5.0M | -$6.2M | $4.1M | $8.1M | $9.6M | -$7.4M | -$38.9M |
| Gross margin | 60.9% | 62.2% | 69.2% | 67.1% | 69.0% | 72.4% | 69.6% | 66.7% |
| Operating margin | -15.0% | -10.1% | 9.2% | -5.2% | 8.7% | -2.8% | -11.8% | -56.2% |
| Net margin | -41.4% | -10.8% | 5.7% | -7.5% | 10.5% | -6.5% | -14.6% | -61.9% |
Company news
Coming soonHeadlines for WGSWW will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.